BUSINESS● LOWJun 24 · Jun 24, 2026, 10:52 AM
Lilly inks R&D deal worth up to $1.9B with China’s Abbisko
Seeking Alpha Tech
Lilly has finalized a research and development agreement with China's Abbisko, potentially valued at up to $1.9 billion. This represents a substantial collaboration in the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoRailway employees protest outsourcing, seek filling of vacancies in South Western RailwayThe HinduBUSINESS21m agoSugarcane farmers threaten highway blockade from October 13The Hindu